Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.

Dejnirattisai W., Shaw RH., Supasa P., Liu C., Stuart AS., Pollard AJ., Liu X., Lambe T., Crook D., Stuart DI., Mongkolsapaya J., Nguyen-Van-Tam JS., Snape MD., Screaton GR., Com-COV2 study group None.

DOI

10.1016/s0140-6736(21)02844-0

Type

Journal article

Journal

Lancet (London, England)

Publication Date

20/12/2021

Addresses

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 9DU, UK; Chinese Academy of Medical Science, Oxford Institute, University of Oxford, Oxford OX3 9DU, UK.

Keywords

Com-COV2 study group

Permalink Original publication